Search
Sarepta Therapeutics Inc
SRPTAdd to Watchlist
18.200USD
+0.230+1.28%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
1.92BMarket Cap
29.21P/E TTM
Sarepta Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
2.20B
15.58%
EPS(YoY)
-7.13
-387.99%
Analyst Rating
HOLD
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its total revenue reached 2.20B, with a year-on-year change of 15.58.
What are the current assets of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its current assets were 2.54B, with a year-on-year change of -17.42.
What are the total assets of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its total assets of Sarepta Therapeutics Inc were 3.35B, with a year-on-year change of -15.48.
What are the total liabilities of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its total liabilities of Sarepta Therapeutics Inc were 2.21B, with a year-on-year change of -9.29.
What is the total equity of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its total equity of Sarepta Therapeutics Inc was 1.14B, with a year-on-year change of -25.34.
What is the net investment of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its net investment of Sarepta Therapeutics Inc was 69.64M, with a year-on-year change of -90.78.
What is the net financing of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its net financing of Sarepta Therapeutics Inc was -168.34M, with a year-on-year change of -234.88.
What is the Earnings Per Share (EPS) of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -7.13, with a year-on-year change of -387.99.
What is the net margin of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its net profit margin was -32.45, with a year-on-year change of -362.40.
What is the gross margin of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its gross margin was 69.21, with a year-on-year change of -16.72.
What is the debt-to-asset ratio of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 24.75, with a year-on-year change of -13.75.
What is the Return on Equity (ROE) of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -53.47, with a year-on-year change of -371.30.
What is the Return on Assets (ROA) of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -19.51, with a year-on-year change of -399.74.
What is the operating profit of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2025 earnings report, its operating profit was -492.47M, with a year-on-year change of -325.82.